Home › Funds › D. E. Shaw & Co › CGEM
D. E. Shaw & Co position in CGEM
CULLINAN THERAPEUTICS INC · Health Care
Latest position (Q4 2025)14.37K sh
Reported value held$148.68K
Portfolio Weight0.00%
First reportedQ2 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2022 | 94.99K | $1.22M | New |
| Q3 2022 | 77.44K | $993.00K | Reduce |
| Q4 2022 | 99.70K | $1.05M | Add |
| Q1 2023 | 73.57K | $752.64K | Reduce |
| Q2 2023 | 55.95K | $601.97K | Reduce |
| Q3 2023 | 39.70K | $359.30K | Reduce |
| Q4 2023 | 48.92K | $498.49K | Add |
| Q1 2024 | 61.62K | $1.05M | Add |
| Q2 2024 | 212.45K | $3.71M | Add |
| Q3 2024 | 59.24K | $991.68K | Reduce |
| Q4 2024 | 48.93K | $595.99K | Reduce |
| Q1 2025 | 31.49K | $238.41K | Reduce |
| Q2 2025 | 25.33K | $190.73K | Reduce |
| Q3 2025 | 25.62K | $151.92K | Add |
| Q4 2025 | 14.37K | $148.68K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CGEM
- BlackRock Inc 5.23M sh · $95.29M · Q2 2026
- Vanguard Group 3.30M sh · $34.14M · Q4 2025
- Geode Capital Management 1.55M sh · $28.18M · Q2 2026
- Goldman Sachs Group 1.00M sh · $18.24M · Q2 2026
- Morgan Stanley 629.03K sh · $11.45M · Q2 2026
- AQR Capital Management 581.34K sh · $10.59M · Q2 2026
- Northern Trust Corp 571.08K sh · $10.40M · Q2 2026
- Bank of America Corp 510.32K sh · $9.29M · Q2 2026
- Charles Schwab Investment Management 464.03K sh · $8.45M · Q2 2026
- Deutsche Bank AG 382.84K sh · $6.97M · Q2 2026
- Millennium Management 366.23K sh · $6.67M · Q2 2026
- Renaissance Technologies 326.81K sh · $5.95M · Q2 2026